mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.02 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.081 |
0.02 |